Cover ImageSALE
Market Research Report

Global Tumor Ablation Market 2015-2019

Published by TechNavio (Infiniti Research Ltd.) Product code 348242
Published Content info 70 Pages
Immediate Delivery Available
Price
Back to Top
Global Tumor Ablation Market 2015-2019
Published: December 30, 2015 Content info: 70 Pages
Description

Market outlook of the global tumor ablation market

Tumor ablation is a minimally invasive, image-guided treatment procedure that is used to destroy cancer cells in the chest, lung, and liver. Recent advances in semiconductor technology and modifications to the design of medical laser systems such as MRI or ultrasound are responsible for this markets healthy growth rate of more than 15% during the forecast period.

Geographically, the EMEA region is expected to account for the highest market share during the forecast period. The growing prevalence of cancer in countries such as Denmark, Belgium, France, and Norway is responsible for this regions high market share of close to 37% by 2019.

Segmentation by ablation technology and analysis of the tumor ablation market

  • Radiofrequency
  • Ultrasound
  • Cryotherapy
  • Microwave

In this market research report, Technavio analysts estimate the radiofrequency segment to account for approximately 13% of the total market share by 2019. Radiofrequency is very specific for treating target tissues without causing significant damage to surrounding healthy cells. The high efficacy rate of this procedure is expected to bolster its growth during the forecast period.

Cancer-type segmentation of the tumor ablation market

  • Liver
  • Breast
  • Prostate
  • Gynecological
  • Lung
  • ENT

Technavios analyst has estimated the liver cancer segment to account for the highest market share during the forecast period. Liver cancer is more common in men than in women and is characterized by uncontrolled cell division in the liver. High incidence of primary liver cancer and bile duct cancer among the populace will result in this segments high market dominion during the forecast period.

Competitive landscape and key vendors

This market offers ample growth opportunities to vendors during the forecast period and is characterized by the presence of numerous local and multinational vendors. While the international players are continually increasing their footprint in the market through product innovations, local vendors adopt collaborations to stay competitive in the market.

Leading vendors in this market are-

  • AngioDynamics
  • Boston Scientific
  • Ethicon
  • Medtronic

Other prominent vendors are Alpinion Medical System, BSD Medical, Conmed, C2 Therapeutics, CSA Medical, C.R. Bard, Chongqing Haifu Medical Technology, Esaote, EDAP TMS, Galil Medical, InSightec, Misonix, Mermaid Medical, Monteris Medical, Neuwave Medical, Olympus, Perseon, Plasma Surgical, Profound Medical, Philips Healthcare, Smith & Nephews, Sonacare Medical, Shenzhen Huikang Medical Apparatus, Terumo Medical, Total Vein Systems, Theraclion, and Vivant Medical.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2019
  • What are the key factors driving the global tumor ablation market
  • What are the key market trends impacting the growth of the global tumor ablation market
  • What are the challenges to market growth
  • Who are the key vendors in the global tumor ablation market
  • What are the market opportunities and threats faced by the vendors in the global tumor ablation market
  • Trending factors influencing the market shares of the EMEA, Americas, and APAC
  • What are the key outcomes of the five forces analysis of the global tumor ablation market

Technavio also offers customization on reports based on specific client requirement.

Table of Contents
Product Code: IRTNTR7589

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Cancer statistics

PART 06: Pipeline analysis

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 08: Market segmentation by ablation technology

  • Radiofrequency ablation
  • Ultrasound ablation
  • Cryoablation
  • Microwave ablation

PART 09: Market segmentation by cancer types

  • Liver cancer
  • Breast cancer
  • Prostate cancer
  • Gynecological cancer
  • Lung cancer
  • Ear, nose, and throat cancers

PART 10: Geographical segmentation

  • Segmentation of global tumor ablation market by geography 2014-2019
  • Tumor ablation market in Americas
  • Tumor ablation market in EMEA
  • Tumor ablation market in APAC

PART 11: Market drivers

  • Increase in minimally invasive surgeries/procedures
  • Rise in number of outpatient procedures
  • Advances in technology
  • Use of medical lasers for oncology procedures

PART 12: Impact of drivers

PART 13: Market challenges

  • High cost of surgeries
  • Risks associated with unskilled practitioners
  • Risks associated with laser tumor ablation treatments
  • Stringent regulatory approval process

PART 14: Impact of drivers and challenges

PART 15: Market trends

  • Use of robotic navigation technologies
  • Growing focus on emerging countries
  • Focus on R&D
  • Rise in accessibility of advanced laser treatments

PART 16: Vendor landscape

  • Competitive scenario
  • Key vendor analysis 2014
  • Other prominent vendors

PART 17: Key vendor analysis

  • AngioDynamics
  • Boston Scientific
  • Ethicon
  • Medtronic

PART 18: Appendix

  • List of abbreviations

PART 19: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Most prevalent cancer types in the world 2012
  • Exhibit 03: Countries with the highest cancer rate 2012
  • Exhibit 04: Pipeline analysis for tumor ablation devices
  • Exhibit 05: Global tumor ablation market segmentation
  • Exhibit 06: Global tumor ablation market 2014-2019 ($ millions)
  • Exhibit 07: Five forces analysis
  • Exhibit 08: Segmentation of global tumor ablation market by technology
  • Exhibit 09: Segmentation of global tumor ablation market by ablation technology 2014
  • Exhibit 10: Segmentation of global tumor ablation market by cancer types
  • Exhibit 11: Segmentation of global tumor ablation market by cancer type 2014
  • Exhibit 12: Segmentation of global tumor ablation market by geography 2014
  • Exhibit 13: Segmentation of global tumor ablation market by geography 2019
  • Exhibit 14: Segmentation of global tumor ablation market by geography 2014-2019
  • Exhibit 15: Image-guided minimally invasive procedures 2012 (million/year)
  • Exhibit 16: Tumor ablation market in Americas 2014-2019 ($ millions)
  • Exhibit 17: Prostate cancer incidence in top five European countries 2012
  • Exhibit 18: Tumor ablation market in EMEA 2014-2019 ($ millions)
  • Exhibit 19: Tumor ablation market in APAC 2014-2019 ($ millions)
  • Exhibit 20: Impact of drivers
  • Exhibit 21: Cost comparison of various tumor ablation procedures
  • Exhibit 22: Impact of drivers and challenges
  • Exhibit 23: Country wise healthcare spending 2010-2016 estimated ($ billions)
  • Exhibit 24: AngioDynamics: Key takeaways
  • Exhibit 25: Boston Scientific: Key takeaways
  • Exhibit 26: Ethicon: Key takeaways
  • Exhibit 27: Medtronic: Key takeaways
  • Exhibit 28: AngioDynamics: Business segmentation by revenue 2015
  • Exhibit 29: AngioDynamics: Business segmentation by revenue 2014 and 2015 ($ millions)
  • Exhibit 30: AngioDynamics: Segmentation of revenue by geography 2015
  • Exhibit 31: Boston Scientific: Business segmentation by revenue 2014
  • Exhibit 32: Boston Scientific: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 33: Ethicon : Product segmentation
  • Exhibit 34: Medtronic: Business segmentation 2015 by revenue
  • Exhibit 35: Medtronic: Business segmentation by revenue 2014 and 2015 ($ billions)
Back to Top